Halozyme Therapeutics
HALO
#1703
Rank
C$17.76 B
Marketcap
C$156.52
Share price
2.73%
Change (1 day)
56.55%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): C$0.82 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.66 Billion. In 2025 the company made an earning of C$0.66 Billion a decrease over its 2024 earnings that were of C$0.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.82 B23.6%
2025 C$0.66 B-16.2%
2024 C$0.79 B59.94%
2023 C$0.49 B39.94%
2022 C$0.35 B0.16%
2021 C$0.35 B92.2%
2020 C$0.18 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$87.77 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$45.92 Million-52.86%
2014 -C$97.42 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$76.3 Million169.94%
2011 -C$28.27 Million-63.44%
2010 -C$77.31 Million-7.19%
2009 -C$83.29 Million15.91%
2008 -C$71.86 Million83.89%
2007 -C$39.08 Million78.1%
2006 -C$21.95 Million16%
2005 -C$18.92 Million45.24%
2004 -C$13.03 Million682.42%
2003 -C$1.67 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.33 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.84 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$47.86 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.20 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.69 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$69.32 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA